BOSTON – Despite fears of a rare but potentially fatal adverse reaction with use of allopurinol, the drug modestly reduces risk of death in patients with hyperuricemia and gout, according to a recent study. The... View Article
SAN DIEGO – Treating gouty arthritis is problematic in patients who have contraindications for, or are unresponsive or intolerant of, nonsteroidal antiinflammatory drugs (NSAIDs) or colchicine. A new study has found, however, that canakinumab (CAN),... View Article
© 2000-2017. All Materials Copyright Marathon Medical Communications, Inc.